Arcutis Biotherapeutics, Inc. ARQT Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares)?
- Arcutis Biotherapeutics, Inc. (ARQT) reported common stock, shares authorized (in shares) of $300M in Q1 2026.
- How has Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares) changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $300M to $300M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $300M to $300M.